PortugalOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biomedical Engineering
Rank in SubField 1: 2,064 out of 148,458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 258,675 | 259,286 |
| Total Cites | 447 | 501 |
| H-index | 10 | 11 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 6 | 6 |
| Total Cites to Single+First Authored Papers | 74 | 80 |
| Number of Single+First+Last Authored Papers | 17 | 17 |
| Total Cites to Single+First+Last Authored Papers | 114 | 138 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 420 | 432 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.16 |
| Self-Citation Percentage |
10.78%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 2,148 out of 140,593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 265,393 | 257,380 |
| Total Cites | 451 | 499 |
| H-index | 12 | 13 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 6 | 6 |
| Total Cites to Single+First Authored Papers | 69 | 76 |
| Number of Single+First+Last Authored Papers | 13 | 13 |
| Total Cites to Single+First+Last Authored Papers | 93 | 107 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 413 | 425 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.17 |
| Self-Citation Percentage |
9.62%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 2,154 out of 134,745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 265,299 | 259,980 |
| Total Cites | 405 | 466 |
| H-index | 12 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 6 | 6 |
| Total Cites to Single+First Authored Papers | 67 | 79 |
| Number of Single+First+Last Authored Papers | 10 | 10 |
| Total Cites to Single+First+Last Authored Papers | 71 | 85 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 357 | 370 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.26 |
| Self-Citation Percentage |
13.09%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biotechnology
Rank in SubField 1: 2,694 out of 131,063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 320,022 | 267,276 |
| Total Cites | 470 | 587 |
| H-index | 13 | 16 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 6 | 6 |
| Total Cites to Single+First Authored Papers | 113 | 153 |
| Number of Single+First+Last Authored Papers | 6 | 6 |
| Total Cites to Single+First+Last Authored Papers | 113 | 153 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 417 | 438 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.34 |
| Self-Citation Percentage |
19.93%
|
|
Related Profiles
Top 2% Scientists by Country
236,132 scientists from 167 countries on the 2025 single-year list.
Portugal984 scientists, 32nd in the world
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.